Human Immunity Against Campylobacter Infection

키워드

참고문헌 (119)

1. Skirrow MB, "Campylobacter enteritis: a “new” disease", BMJ, 2, pp.9~11 (1977)
2. Havelaar AH, "World Health Organization global estimates and regional comparisons of the burden of foodborne disease in 2010", PLoS Med, 12, pp.e1001923~ (2010)
3. Humphrey S, "Campylobacter jejuni is not merely a commensal in commercial broiler chickens and affects bird welfare", MBio, 5, pp.e01364~e01314 (2014)
4. Han Z, "Differences in host breed and diet influence colonization by Campylobacter jejuni and induction of local immune responses in chicken", Gut Pathog, 8, pp.56~ (2016)
5. Han Z, "Influence of the gut microbiota composition on Campylobacter jejuni colonization in chickens", Infect Immun, 85, pp.e00380~e00317 (2017)
6. Sahin O, "Effect of Campylobacter-specific maternal antibodies on Campylobacter jejuni colonization in young chickens", Appl Environ Microbiol, 69, pp.5372~5379 (2003)
7. Shoaf-Sweeney KD, "Identification of Campylobacter jejuni proteins recognized by maternal antibodies of chickens", Appl Environ Microbiol, 74, pp.6867~6875 (2008)
8. Cawthraw S, "Isotype, specificity, and kinetics of systemic and mucosal antibodies to Campylobacter jejuni antigens, including flagellin, during experimental oral infections of chickens", Avian Dis, 38, pp.341~349 (1994)
9. Lacharme-Lora L, "B lymphocytes play a limited role in clearance of Campylobacter jejuni from the chicken intestinal tract", Sci Rep, 7, pp.45090~ (2017)
10. Van Deun K, "Colonization strategy of Campylobacter jejuni results in persistent infection of the chicken gut", Vet Microbiol, 130, pp.285~297 (2008)
11. Berndtson E, "Campylobacter incidence on a chicken farm and the spread of Campylobacter during the slaughter process", Int J Food Microbiol, 32, pp.35~47 (1996)
12. Iovine NM, "Campylobacter", pp.337~344 (2008), ASM Press
13. Bacon DJ, "A phase-variable capsule is involved in virulence of Campylobacter jejuni 81-176", Mol Microbiol, 40, pp.769~777 (2001)
14. Jin S, "JlpA, a novel surface-exposed lipoprotein specific to Campylobacter jejuni, mediates adherence to host epithelial cells", Mol Microbiol, 39, pp.1225~1236 (2001)
15. Monteville MR, "Maximal adherence and invasion of INT 407 cells by Campylobacter jejuni requires the CadF outer-membrane protein and microfilament reorganization", Microbiology, 149, pp.153~165 (2003)
16. Tu QV, "Campylobacter jejuni response to human mucin MUC2: modulation of colonization and pathogenicity determinants", J Med Microbiol, 57, pp.795~802 (2008)
17. Stahl M, "Insights into Campylobacter jejuni colonization of the mammalian intestinal tract using a novel mouse model of infection", Gut Microbes, 6, pp.143~148 (2015)
18. Hu L, "Enhanced microscopic definition of Campylobacter jejuni 81-176 adherence to, invasion of, translocation across, and exocytosis from polarized human intestinal Caco-2 cells", Infect Immun, 76, pp.5294~5304 (2008)
19. Watson RO, "Campylobacter jejuni survives within epithelial cells by avoiding delivery to lysosomes", PLoS Pathog, 4, pp.e14~ (2008)
20. Guerrant RL, "Production of a unique cytotoxin by Campylobacter jejuni", Infect Immun, 55, pp.2526~2530 (1987)
21. Whitehouse CA, "Campylobacter jejuni cytolethal distending toxin causes a G2-phase cell cycle block", Infect Immun, 66, pp.1934~1940 (1998)
22. O Cróinín T, "Host epithelial cell invasion by Campylobacter jejuni: trigger or zipper mechanism", Front Cell Infect Microbiol, 2, pp.25~ (2012)
23. van Spreeuwel JP, "Campylobacter colitis: histological immunohistochemical and ultrastructural findings", Gut, 26, pp.945~951 (1985)
24. Black RE, "Experimental Campylobacter jejuni infection in humans", J Infect Dis, 157, pp.472~479 (1988)
25. Perkins DJ, "Campylobacter jejuni enterocolitis causing peritonitis, ileitis and intestinal obstruction", Aust N Z J Surg, 64, pp.55~58 (1994)
26. Samie A, "Prevalence, haemolytic and haemagglutination activities and antibiotic susceptibility profiles of Campylobacter spp. isolated from human diarrhoeal stools in Vhembe District, South Africa", J Health Popul Nutr, 25, pp.406~413 (2007)
27. Endtz HP, "Molecular characterization of Campylobacter jejuni from patients with Guillain-Barré and Miller Fisher syndromes", J Clin Microbiol, 38, pp.2297~2301 (2000)
28. McCarthy N, "Incidence of Guillain-Barré syndrome following infection with Campylobacter jejuni", Am J Epidemiol, 153, pp.610~614 (2001)
29. Godschalk PC, "Structural characterization of Campylobacter jejuni lipooligosaccharide outer cores associated with Guillain-Barre and Miller Fisher syndromes", Infect Immun, 75, pp.1245~1254 (2007)
30. Houliston RS, "Lipooligosaccharide of Campylobacter jejuni: similarity with multiple types of mammalian glycans beyond gangliosides", J Biol Chem, 286, pp.12361~12370 (2011)
31. Apel D, "Characterization of Campylobacter jejuni RacRS reveals roles in the heat shock response, motility, and maintenance of cell length homogeneity", J Bacteriol, 194, pp.2342~2354 (2012)
32. Friis LM, "Campylobacter jejuni drives MyD88-independent interleukin-6 secretion via Toll-like receptor 2", Infect Immun, 77, pp.1553~1560 (2009)
33. Bouwman LI, "activation by Campylobacter jejuni", J Immunol, 193, pp.4548~4557 (2014)
34. Shang Y, "Insights into Campylobacter jejuni colonization and enteritis using a novel infant rabbit model", Sci Rep, 6, pp.28737~ (2016)
35. Svensson L, "Human eosinophils selectively recognize and become activated by bacteria belonging to different taxonomic groups", Microbes Infect, 7, pp.720~728 (2005)
36. El-Salhy M, "Changes in the symptom pattern and the densities of large-intestinal endocrine cells following Campylobacter infection in irritable bowel syndrome: a case report", BMC Res Notes, 6, pp.391~ (2013)
37. Hickey TE, "Campylobacter jejuni cytolethal distending toxin mediates release of interleukin-8 from intestinal epithelial cells", Infect Immun, 68, pp.6535~6541 (2000)
38. Jin S, "JlpA of Campylobacter jejuni interacts with surface-exposed heat shock protein 90α and triggers signalling pathways leading to the activation of NF‐κB and p38 MAP kinase in epithelial cells", Cell Microbiol, 5, pp.165~174 (2003)
39. Andersen-Nissen E, "Evasion of Toll-like receptor 5 by flagellated bacteria", Proc Natl Acad Sci U S A, 102, pp.9247~9252 (2005)
40. Hu L, "Campylobacter jejuni induces maturation and cytokine production in human dendritic cells", Infect Immun, 74, pp.2697~2705 (2006)
41. Zheng J, "Campylobacter-induced interleukin-8 secretion in polarized human intestinal epithelial cells requires Campylobacter-secreted cytolethal distending toxin- and Toll-like receptor-mediated activation of NF-κB", Infect Immun, 76, pp.4498~4508 (2008)
42. de Zoete MR, "Activation of human and chicken Toll-like receptors by Campylobacter spp", Infect Immun, 78, pp.1229~1238 (2010)
43. O'Hara JR, "Campylobacter jejuni disrupts protective Toll-like receptor 9 signaling in colonic epithelial cells and increases the severity of dextran sulfate sodium-induced colitis in mice", Infect Immun, 80, pp.1563~1571 (2012)
44. Stephenson HN, "Campylobacter jejuni lipooligosaccharide sialylation, phosphorylation, and amide", ester linkage modifications fine-tune human Toll-like receptor 4 activation, 2013, pp.288, 19661~19672
45. Stahl M, "A novel mouse model of Campylobacter jejuni gastroenteritis reveals key pro-inflammatory and tissue protective roles for Toll-like receptor signaling during infection", PLoS Pathog, 10, pp.e1004264~ (2014)
46. Wesche H, "MyD88: an adapter that recruits IRAK to the IL-1 receptor complex", Immunity, 7, pp.837~847 (1997)
47. Verstak B, "MyD88 adapter-like (Mal)", TIRAP interaction with TRAF6 is critical for TLR2- and TLR4-mediated NF-κB proinflammatory responses, 2009, pp.284, 24192~24203
48. Hickey TE, "Campylobacter jejuni-stimulated secretion of interleukin-8 by INT407 cells", Infect Immun, 67, pp.88~93 (1999)
49. Mellits KH, "Activation of the transcription factor NF-κB by Campylobacter jejuni", Microbiology, 148, pp.2753~2763 (2002)
50. Jones MA, "Induction of proinflammatory responses in the human monocytic cell line THP-1 by Campylobacter jejuni", Infect Immun, 71, pp.2626~2633 (2003)
51. John DA, "The bacterial species Campylobacter jejuni induce diverse innate immune responses in human and avian intestinal epithelial cells", Front Microbiol, 8, pp.1840~ (2017)
52. Kawai T, "Lipopolysaccharide stimulates the MyD88-independent pathway and results in activation of IFN-regulatory factor 3 and the expression of a subset of lipopolysaccharide-inducible genes", J Immunol, 167, pp.5887~5894 (2001)
53. Yamamoto M, "Cutting edge: a novel Toll", IL-1 receptor domain-containing adapter that preferentially activates the IFN-beta promoter in the Toll-like receptor signaling, 2002, pp.169, 6668~6672
54. Nilsen NJ, "A role for the adaptor proteins TRAM and TRIF in toll-like receptor 2 signaling", J Biol Chem, 290, pp.3209~3222 (2015)
55. Bakhiet M, "Induction of α and β chemokines by intestinal epithelial cells stimulated with Campylobacter jejuni", J Infect, 48, pp.236~244 (2004)
56. Hu L, "Campylobacter jejuni induces secretion of proinflammatory chemokines from human intestinal epithelial cells", Infect Immun, 73, pp.4437~4440 (2005)
57. Johanesen PA, "Flagellin-independent regulation of chemokine host defense in Campylobacter jejuni-infected intestinal epithelium", Infect Immun, 74, pp.3437~3447 (2006)
58. Al-Sayeqh AF, "Campylobacter jejuni activates NF-κB independently of TLR2, TLR4, Nod1 and Nod2 receptors", Microb Pathog, 49, pp.294~304 (2010)
59. Elmi A, "Campylobacter jejuni outer membrane vesicles play an important role in bacterial interactions with human intestinal epithelial cells", Infect Immun, 80, pp.4089~4098 (2012)
60. Konkel ME, "Invasion of epithelial cells by Campylobacter jejuni is independent of caveolae", Cell Commun Signal, 11, pp.100~ (2013)
61. Zilbauer M, "A major role for intestinal epithelial nucleotide oligomerization domain 1 (NOD1) in eliciting host bactericidal immune responses to Campylobacter jejuni", Cell Microbiol, 9, pp.2404~2416 (2007)
62. Zhao Y, "The NLRC4 inflammasome receptors for bacterial flagellin and type III secretion apparatus", Nature, 477, pp.596~600 (2011)
63. Grimes CL, "The innate immune protein Nod2 binds directly to MDP, a bacterial cell wall fragment", J Am Chem Soc, 134, pp.13535~13537 (2012)
64. Girardin SE, "Peptidoglycan molecular requirements allowing detection by Nod1 and Nod2", J Biol Chem, 278, pp.41702~41708 (2003)
65. Zilbauer M, "Intestinal innate immunity to Campylobacter jejuni results in induction of bactericidal human beta-defensins 2 and 3", Infect Immun, 73, pp.7281~7289 (2005)
66. Murphy H, "Direction of neutrophil movements by Campylobacter-infected intestinal epithelium", Microbes Infect, 13, pp.42~48 (2011)
67. Pétrilli V, "Activation of the NALP3 inflammasome is triggered by low intracellular potassium concentration", Cell Death Differ, 14, pp.1583~1589 (2007)
68. Stahl M, "The first line of defense: the role of epithelial cell inflammasomes in controlling Campylobacter jejuni infection", J Can Assoc Gastroenterol, 1, pp.401~ (2018)
69. Jung HC, "A distinct array of proinflammatory cytokines is expressed in human colon epithelial cells in response to bacterial invasion", J Clin Invest, 95, pp.55~65 (1995)
70. Sun X, "Phosphatidylinositol 3-kinase-γ signaling promotes Campylobacter jejuni-induced colitis through neutrophil recruitment in mice", J Immunol, 190, pp.357~365 (2013)
71. Sørensen NB, "Neutrophil activation by Campylobacter concisus", Gut Pathog, 5, pp.17~ (2013)
72. Kiehlbauch JA, "Phagocytosis of Campylobacter jejuni and its intracellular survival in mononuclear phagocytes", Infect Immun, 48, pp.446~451 (1985)
73. Wassenaar TM, "Differential uptake and killing potential of Campylobacter jejuni by human peripheral monocytes", macrophages, 1997, pp.186, 139~144
74. Avril T, "Sialic acid-binding immunoglobulin-like lectin 7 mediates selective recognition of sialylated glycans expressed on Campylobacter jejuni lipooligosaccharides", Infect Immun, 74, pp.4133~4141 (2006)
75. Purdy D, "Generation of a superoxide dismutase (SOD)-deficient mutant of Campylobacter coli: evidence for the significance of SOD in Campylobacter survival and colonization", Appl Environ Microbiol, 65, pp.2540~2546 (1999)
76. Keo T, "Campylobacter capsule and lipooligosaccharide confer resistance to serum and cationic antimicrobials", Virulence, 2, pp.30~40 (2011)
77. Walan A, "Phagocyte killing of Campylobacter jejuni in relation to oxidative activation", APMIS, 100, pp.424~430 (1992)
78. Everest P, "Campylobacter Molecular and Cellular Biology", pp.429~ (2005), Horizon Bioscience
79. Bär W, "Role of murine macrophages and complement in experimental Campylobacter infection", J Med Microbiol, 26, pp.55~59 (1988)
80. Hickey TE, "Intracellular survival of Campylobacter jejuni in human monocytic cells and induction of apoptotic death by cytholethal distending toxin", Infect Immun, 73, pp.5194~5197 (2005)
81. Heikema AP, "Enhanced, sialoadhesin-dependent uptake of Guillain-Barre syndrome-associated Campylobacter jejuni strains by human macrophages", Infect Immun, 81, pp.2095~2103 (2013)
82. van Sorge NM, "N-glycosylated proteins and distinct lipooligosaccharide glycoforms of Campylobacter jejuni target the human C-type lectin receptor MGL", Cell Microbiol, 11, pp.1768~1781 (2009)
83. Day WA Jr, "Role of catalase in Campylobacter jejuni intracellular survival", Infect Immun, 68, pp.6337~6345 (2000)
84. Klaas M, "Sialoadhesin promotes rapid proinflammatory and type I IFN responses to a sialylated pathogen, Campylobacter jejuni", J Immunol, 189, pp.2414~2422 (2012)
85. Korneev KV, "Hypoacylated LPS from foodborne pathogen Campylobacter jejuni induces moderate TLR4-mediated inflammatory response in murine macrophages", Front Cell Infect Microbiol, 8, pp.58~ (2018)
86. Iovine NM, "Reactive nitrogen species contribute to innate host defense against Campylobacter jejuni", Infect Immun, 76, pp.986~993 (2008)
87. Bax M, "Campylobacter jejuni lipooligosaccharides modulate dendritic cell-mediated T cell polarization in a sialic acid linkage-dependent manner", Infect Immun, 79, pp.2681~2689 (2011)
88. Gordon S, "Alternative activation of macrophages: mechanism and functions", Immunity, 32, pp.593~604 (2010)
89. Fehlings M, "Comparative analysis of the interaction of Helicobacter pylori with human dendritic cells, macrophages, and monocytes", Infect Immun, 80, pp.2724~2734 (2012)
90. Rescigno M, "Dendritic cells express tight junction proteins and penetrate gut epithelial monolayers to sample bacteria", Nat Immunol, 2, pp.361~367 (2001)
91. Niess JH, "CX3CR1-mediated dendritic cell access to the intestinal lumen and bacterial clearance", Science, 307, pp.254~258 (2005)
92. Hu L, "Campylobacter jejuni 81-176 associates with microtubules and dynein during invasion of human intestinal cells", Infect Immun, 67, pp.4171~4182 (1999)
93. Kuijf ML, "TLR4-mediated sensing of Campylobacter jejuni by dendritic cells is determined by sialylation", J Immunol, 185, pp.748~755 (2010)
94. Huizinga R, "Sialylation of Campylobacter jejuni endotoxin promotes dendritic cell-mediated B cell responses through CD14-dependent production of IFN-β and TNF-α", J Immunol, 191, pp.5636~5645 (2013)
95. Rathinam VA, "Campylobacter jejuni-induced activation of dendritic cells involves cooperative signaling through Toll-like receptor 4 (TLR4)-MyD88 and TLR4-TRIF axes", Infect Immun, 77, pp.2499~2507 (2009)
96. Baqar S, "Campylobacter Study Team Recrudescent Campylobacter jejuni infection in an immunocompetent adult following experimental infection with a well-characterized organism", Clin Vaccine Immunol, 17, pp.80~86 (2010)
97. Spiller RC, "Increased rectal mucosal enteroendocrine cells, T lymphocytes, and increased gut permeability following acute Campylobacter enteritis and in post-dysenteric irritable bowel syndrome", Gut, 47, pp.804~811 (2000)
98. Cho Y, "CD4+ and CD8+ T cells cooperate to improve prognosis of patients with esophageal squamous cell carcinoma", Cancer Res, 63, pp.1555~1559 (2003)
99. He Z, "Campylobacter jejuni promotes colorectal tumorigenesis through the action of cytolethal distending toxin", Gut, 68, pp.289~300 (2019)
100. Edwards LA, "Delineation of the innate and adaptive T-cell immune outcome in the human host in response to Campylobacter jejuni infection", PLoS One, 5, pp.e15398~ (2010)
101. Malik A, "Contrasting immune responses mediate Campylobacter jejuni-induced colitis and autoimmunity", Mucosal Immunol, 7, pp.802~817 (2014)
102. Fimlaid KA, "Peripheral CD4+ T cell cytokine responses following human challenge and re-challenge with Campylobacter jejuni", PLoS One, 9, pp.e112513~ (2014)
103. Li S, "Circulating Th17, Th22, and Th1 cells are elevated in the Guillain-Barré syndrome and downregulated by IVIg treatments", Mediators Inflamm, 2014, pp.740947~ (2014)
104. Bereswill S, "Immune responses upon Campylobacter jejuni infection of secondary abiotic mice lacking nucleotide-oligomerization-domain-2", Gut Pathog, 9, pp.33~ (2017)
105. Blaser MJ, "Campylobacter jejuni outer membrane proteins are antigenic for humans", Infect Immun, 43, pp.986~993 (1984)
106. Kirimat M, "Antibodies to Campylobacter flagellin recognize epitopes common to phase 1 and phase 2 flagella", Res Microbiol, 140, pp.645~651 (1989)
107. Strid MA, "Antibody responses to Campylobacter infections determined by an enzyme-linked immunosorbent assay: 2-year follow-up study of 210 patients", Clin Diagn Lab Immunol, 8, pp.314~319 (2001)
108. Cawthraw SA, "Antibodies, directed towards Campylobacter jejuni antigens, in sera from poultry abattoir workers", Clin Exp Immunol, 122, pp.55~60 (2000)
109. Cawthraw SA, "Long-term antibody responses following human infection with Campylobacter jejuni", Clin Exp Immunol, 130, pp.101~106 (2002)
110. Lane EM, "Urine and faecal IgA response during naturally acquired infection with Campylobacter jejuni", Lancet, 1, pp.1141~ (1987)
111. Linton D, "Phase variation of a β-1,3 galactosyltransferase involved in generation of the ganglioside GM1-like lipo-oligosaccharide of Campylobacter jejuni", Mol Microbiol, 37, pp.501~514 (2000)
112. Guerry P, "Phase variation of Campylobacter jejuni 81-176 lipooligosaccharide affects ganglioside mimicry and invasiveness in vitro", Infect Immun, 70, pp.787~793 (2002)
113. Mooney A, "Campylobacter upsaliensis exerts a cytolethal distending toxin effect on HeLa cells and T lymphocytes", Microbiology, 147, pp.735~743 (2001)
114. Vaishnavi C, "C-reactive protein in patients with Guillain Barré syndrome", Indian J Pathol Microbiol, 57, pp.51~54 (2014)
115. 배준열, "Clinical manifestation of Campylobacter enteritis in children", Clinical and Experimental Pediatrics, 61(3), pp.84~89 (2018), 대한소아청소년과학회
116. Blaser MJ, "Campylobacter jejuni-specific serum antibodies are elevated in healthy Bangladeshi children", J Clin Microbiol, 21, pp.164~167 (1985)
117. Fernández H, "Effect of the complement system on the sensitivity of Campylobacter jejuni and Campylobacter coli to human blood serum", Braz J Med Biol Res, 28, pp.227~229 (1995)
118. Maue AC, "The polysaccharide capsule of Campylobacter jejuni modulates the host immune response", Infect Immun, 81, pp.665~672 (2013)
119. Blaser MJ, "Pathogenesis of Campylobacter fetus infections. Failure of encapsulated Campylobacter fetus to bind C3b explains serum and phagocytosis resistance", J Clin Invest, 81, pp.1434~1444 (1988)

관련 논문AI추천